144 related articles for article (PubMed ID: 38345233)
1. Treatment of Gamma Hydroxybutyrate Withdrawal in a Pregnant Female: A Case Report.
Joyce S; Lea S; Woolner M; Leddy A
J Addict Med; 2024 May-Jun 01; 18(3):342-344. PubMed ID: 38345233
[TBL] [Abstract][Full Text] [Related]
2. Successful Management of Gamma-hydroxybutyrate (GHB) Withdrawal Using Baclofen as a Standalone Therapy: A Case Report.
Habibian S; Ahamad K; McLean M; Socias ME
J Addict Med; 2019; 13(5):415-417. PubMed ID: 30907765
[TBL] [Abstract][Full Text] [Related]
3. Baclofen and gamma-hydroxybutyrate withdrawal.
LeTourneau JL; Hagg DS; Smith SM
Neurocrit Care; 2008; 8(3):430-3. PubMed ID: 18266111
[TBL] [Abstract][Full Text] [Related]
4. Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review.
Siefried KJ; Freeman G; Roberts DM; Lindsey R; Rodgers C; Ezard N; Brett J
Psychopharmacology (Berl); 2023 Jan; 240(1):127-135. PubMed ID: 36508055
[TBL] [Abstract][Full Text] [Related]
5. [GHB abuse in a pregnant patient in clinical practice].
Santy T; Heylens G; Audenaert K
Tijdschr Psychiatr; 2020; 62(10):896-900. PubMed ID: 33184821
[TBL] [Abstract][Full Text] [Related]
6. The gamma-hydroxybutyrate withdrawal syndrome.
Tarabar AF; Nelson LS
Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
[TBL] [Abstract][Full Text] [Related]
7. Inpatient Gamma-Hydroxybutyrate Detoxification: A Case Report Describing Day-to-day Therapeutic Management.
von Theobald L; Rousselet M; Cholet J; Debar H; Boels D; Victorri-Vigneau C; Grall-Bronnec M
J Addict Med; 2017; 11(3):231-234. PubMed ID: 28125446
[TBL] [Abstract][Full Text] [Related]
8. Gamma-hydroxybutyrate reduces both withdrawal syndrome and hypercortisolism in severe abstinent alcoholics: an open study vs. diazepam.
Nava F; Premi S; Manzato E; Campagnola W; Lucchini A; Gessa GL
Am J Drug Alcohol Abuse; 2007; 33(3):379-92. PubMed ID: 17613965
[TBL] [Abstract][Full Text] [Related]
9. [Severe delirium after GHB abuse].
Sundal EV; Giil LM
Tidsskr Nor Laegeforen; 2020 Feb; 140(2):. PubMed ID: 32026868
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
McDonough M; Kennedy N; Glasper A; Bearn J
Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
[TBL] [Abstract][Full Text] [Related]
11. Inpatient management of gamma-hydroxybutyrate withdrawal.
Cappetta M; Murnion BP
Australas Psychiatry; 2019 Jun; 27(3):284-287. PubMed ID: 30652947
[TBL] [Abstract][Full Text] [Related]
12. Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol.
Liao PC; Chang HM; Chen LY
J Formos Med Assoc; 2018 Dec; 117(12):1124-1127. PubMed ID: 29933901
[TBL] [Abstract][Full Text] [Related]
13. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review.
Craig K; Gomez HF; McManus JL; Bania TC
J Emerg Med; 2000 Jan; 18(1):65-70. PubMed ID: 10645841
[TBL] [Abstract][Full Text] [Related]
14. Severe GHB withdrawal delirium managed with dexmedetomidine.
Tay EM; Graham RI; Day RO
Med J Aust; 2016 Sep; 205(6):251-2. PubMed ID: 27627929
[No Abstract] [Full Text] [Related]
15. Baclofen as relapse prevention in the treatment of gamma-hydroxybutyrate dependence: a case series.
Kamal RM; Loonen AJ; Dijkstra BA; De Jong CA
J Clin Psychopharmacol; 2015 Jun; 35(3):313-8. PubMed ID: 25900349
[TBL] [Abstract][Full Text] [Related]
16. Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: The Dutch GHB monitor project.
Dijkstra BA; Kamal R; van Noorden MS; de Haan H; Loonen AJ; De Jong CA
Drug Alcohol Depend; 2017 Jan; 170():164-173. PubMed ID: 27923198
[TBL] [Abstract][Full Text] [Related]
17. [GHB withdrawal delirium].
Stijnenbosch PJ; Zuketto C; Beijaert PJ; Maat A
Ned Tijdschr Geneeskd; 2010; 154():A1086. PubMed ID: 20132572
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of severe, treatment resistant GHB withdrawal through thiopental-coma.
Vos CF; Pop-Purceleanu M; van den Berg MJW; Schellekens AFA
Subst Abus; 2021; 42(1):33-38. PubMed ID: 33044905
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of gamma-hydroxybutyrate withdrawal].
Strand NAW; Petersen TS; Nielsen LM; Boegevig S
Ugeskr Laeger; 2017 Dec; 179(50):. PubMed ID: 29260701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
